These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1443436)

  • 21. Monitoring relapse drinking during disulfiram therapy by assay of urinary 5-hydroxytryptophol.
    Helander A
    Alcohol Clin Exp Res; 1998 Feb; 22(1):111-4. PubMed ID: 9514292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for disulfiram-induced liver test dysfunction in an inpatient alcoholism program.
    Wright C; Moore RD; Grodin DM; Spyker DA; Gill EV
    Alcohol Clin Exp Res; 1993 Feb; 17(1):184-6. PubMed ID: 8383924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An open randomized trial comparing disulfiram and topiramate in the treatment of alcohol dependence.
    De Sousa AA; De Sousa J; Kapoor H
    J Subst Abuse Treat; 2008 Jun; 34(4):460-3. PubMed ID: 17629442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A nanoparticle formulation of disulfiram prolongs corneal residence time of the drug and reduces intraocular pressure.
    Nagai N; Yoshioka C; Mano Y; Tnabe W; Ito Y; Okamoto N; Shimomura Y
    Exp Eye Res; 2015 Mar; 132():115-23. PubMed ID: 25633346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent developments in disulfiram treatment.
    Brewer C
    Alcohol Alcohol; 1993 Jul; 28(4):383-95. PubMed ID: 8397520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Supervised disulfiram in relapse prevention in alcohol-dependent patients suffering from comorbid borderline personality disorder--a case series.
    Mutschler J; Grosshans M; Koopmann A; Hermann D; Diehl A; Mann K; Kiefer F
    Alcohol Alcohol; 2010; 45(2):146-50. PubMed ID: 20107104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A disulfiram-alcohol reaction after inhalation of a salbutamol aerosol: a plausible interaction?].
    Choi T; Neven A; Al Hadithy AF
    Tijdschr Psychiatr; 2016; 58(5):407-10. PubMed ID: 27213641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disulfiram implant: a double-blind placebo controlled follow-up on treatment outcome.
    Johnsen J; Mørland J
    Alcohol Clin Exp Res; 1991 Jun; 15(3):532-6. PubMed ID: 1877740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical study of disulfiram in intravenous suspension. A new alternative in the treatment of alcoholism].
    Chandìa R; Cid E; Vallejos C; Avilas JM
    Rev Med Chil; 1990 Aug; 118(8):855-61. PubMed ID: 2152228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endogenous breath ethanol concentrations in abstinent alcohol abusers and normals.
    Phillips M; Greenberg J; Martinez V
    Alcohol; 1988; 5(3):263-5. PubMed ID: 3415770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disulfiram implantation: a dose response trial.
    Wilson A; Blanchard R; Davidson W; McRae L; Maini K
    J Clin Psychiatry; 1984 Jun; 45(6):242-7. PubMed ID: 6202678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of disulfiram-like reaction with metronidazole and ethanol.
    Visapää JP; Tillonen JS; Kaihovaara PS; Salaspuro MP
    Ann Pharmacother; 2002 Jun; 36(6):971-4. PubMed ID: 12022894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of disulfiram implantation in alcoholism.
    Malcolm MT; Madden JS
    Br J Psychiatry; 1973 Jul; 123(572):41-5. PubMed ID: 4729873
    [No Abstract]   [Full Text] [Related]  

  • 34. Development and characterisation of disulfiram-loaded PLGA nanoparticles for the treatment of non-small cell lung cancer.
    Najlah M; Ahmed Z; Iqbal M; Wang Z; Tawari P; Wang W; McConville C
    Eur J Pharm Biopharm; 2017 Mar; 112():224-233. PubMed ID: 27915005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary thioether biological monitoring in the interaction between 1,2-dichloroethane and disulfiram in Sprague-Dawley rats.
    Igwe OJ; Que Hee SS; Wagner WD
    Am Ind Hyg Assoc J; 1988 Jan; 49(1):10-6. PubMed ID: 3344670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose-effect relationship of disulfiram in human volunteers. I: Clinical studies.
    Christensen JK; Møller IW; Rønsted P; Angelo HR; Johansson B
    Pharmacol Toxicol; 1991 Mar; 68(3):163-5. PubMed ID: 2057446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advantages and disadvantages of disulfiram coadministered with popular addictive substances.
    Kleczkowska P; Sulejczak D; Zaremba M
    Eur J Pharmacol; 2021 Aug; 904():174143. PubMed ID: 33971180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disulfiram-Induced De Novo Convulsions without Alcohol Challenge: Case Series and Review of Literature.
    Kulkarni RR; Bairy BK
    Indian J Psychol Med; 2015; 37(3):345-8. PubMed ID: 26664087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats.
    Wang S; Li D; Ito Y; Nabekura T; Wang S; Zhang J; Wu C
    Curr Eye Res; 2004 Jul; 29(1):51-8. PubMed ID: 15370367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tolerance to disulfiram induced by chronic alcohol intake in the rat.
    Tampier L; Quintanilla ME; Israel Y
    Alcohol Clin Exp Res; 2008 Jun; 32(6):937-41. PubMed ID: 18445101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.